Vanishing contrast enhancement in malignant glioma after corticosteroid treatment

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Acta Neurochirurgica

• Publication date

  2004-06-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00701-004-0282-8PMID 15254806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of untreated gliomas by magnetic resonance spectroscopic imaging.

  2002cited by this paper
• Positron emission tomography imaging of brain tumors.

  2002cited by this paper
• Brain tumors.

  2001cited by this paper
• Disappearing cystic cerebellar medulloblastoma: the ghost tumour.

  2001cited by this paper
• Surgery for cerebral gliomas: past, present, and future.

  2000cited by this paper
• The case of the disappearing glioma

  1997cited by this paper
• Quantitation of peritumoural oedema and the effect of steroids using NMR-relaxation time imaging and blood-brain barrier analysis.

  1994cited by this paper
• Primary central nervous system lymphoma: A new clinical challenge

  1991cited by this paper
• The therapy of primary brain lymphoma

  1991cited by this paper
• Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

  1984cited by this paper
• [Disappearance of enhancement of brain tumor in contrast CT scan after excessively high dosage of dexamethasone--suggestive indication of steroid administration by CT scan].

  1983cited by this paper
• The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier.

  1976cited by this paper
• An extravascular component of contrast enhancement in cranial computed tomography. Part II. Contrast enhancement and the blood-tissue barrier.

  1975cited by this paper

• Impact of corticosteroid administration on glioblastoma progression before and after adjuvant treatments: recent updates on contradictory findings and mechanistic interactions

  2026cites this paper
• Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma.

  2025cites this paper
• Acute Evolution of Neurological Signs and Magnetic Resonance Imaging Features in Dogs With Brain Tumors Receiving Treatment With Corticosteroids and Anticonvulsants

  2025cites this paper
• Glioblastoma with markedly reduced contrast enhancement after corticosteroid administration: Increased density and reduced diffusion capability are noteworthy

  2025cites this paper
• “Vanishing” glioblastoma: A case report and review of the literature

  2024cites this paper
• Intraoperative Sonographically Guided Resection of Non-Enhancing Diffuse Gliomas: Study Protocol for a Randomised, Controlled Trial

  2024cites this paper
• Imaging characterization of an adult H3 K27M-altered diffuse midline glioma of the medulla oblongata with a confounding steroid response

  2022cites this paper
• Advantages and drawbacks of dexamethasone in glioblastoma multiforme.

  2022cites this paper
• An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients

  2022cites this paper
• Primary Central Nervous System Lymphoma

  2022cites this paper
• Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study

  2021cites this paper
• Pseudoprogression versus true progression in glioblastoma patients: a multiapproach literature review. Part 2 - Radiological features and metric markers.

  2021cites this paper
• Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity

  2020cites this paper
• Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy

  2020cites this paper
• Use of fluorescein sodium to obtain histological diagnosis of primary Central nervous system lymphoma ghost tumour despite disappearance on intraoperative magnetic resonance imaging: technical note and review of the literature

  2020cites this paper
• Patient-specific parameter estimates of glioblastoma multiforme growth dynamics from a model with explicit birth and death rates

  2019cites this paper
• Correlation of Preoperative Von Willebrand Factor with Magnetic Resonance Imaging Perfusion and Permeability Parameters as Predictors of Prognosis in Glioblastoma.

  2019cites this paper
• Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report

  2019cites this paper
• Corticosteroid-Induced Regression of Glioblastoma: A Radiographic Conundrum

  2019cites this paper
• Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies

  2019cites this paper
• Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma

  2018cites this paper
• Investigation of the usefulness of fluorescein sodium fluorescence in stereotactic brain biopsy

  2018cites this paper
• Post-gadolinium 3-dimensional spatial, surface, and structural characteristics of glioblastomas differentiate pseudoprogression from true tumor progression

  2018cites this paper
• Management of primary central nervous system lymphoma.

  2018cites this paper
• Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas

  2017cites this paper
• The Fluoropen: a simple low-cost device to detect intraoperative fluorescein fluorescence in stereotactic needle biopsy of brain tumors

  2017cites this paper
• The Impact of Corticother apy on the Dia gnostic Yield of Stereotactic Biopsy in Patients with Brain Lymphoma

  2017cites this paper
• Benefit of 3T Diffusion-weighted Imaging in Comparison to Contrast-enhanced MR Imaging for the Evaluation of Disseminated Lesions in Primary Malignant Brain Tumors

  2016cites this paper
• Chapter 10 – Imaging in Oncology

  2016cites this paper
• Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation

  2015cites this paper
• Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI–Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas

  2015cites this paper
• Exclusion of a Brain Lesion: Is Intravenous Contrast Administration Required after Normal Precontrast Magnetic Resonance Imaging?

  2014cites this paper
• A systematic approach to the diagnosis of suspected central nervous system lymphoma.

  2013cites this paper
• Vanishing glioblastoma after corticosteroid therapy: does this occurrence modify our surgical strategy?

  2013cites this paper
• Glioblastoma Presenting with Steroid-Induced Pseudoregression of Contrast Enhancement on Magnetic Resonance Imaging

  2012cites this paper
• Imaging diagnosis--lack of contrast enhancement in metastatic cerebral adenocarcinoma.

  2012cites this paper
• Imaging in Oncology

  2011cites this paper
• Contrast media enhancement of intracranial lesions in magnetic resonance imaging does not reflect histopathologic findings consistently.

  2011cites this paper
• Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

  2011cites this paper
• Principles of Supportive Care

  2011cites this paper
• [Confusion in a 60-year-old man].

  2010cites this paper
• A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse.

  2010cites this paper
• Glioblastoma multiforme fades on CT imaging after dexamethasone therapy.

  2009cites this paper
• Vanishing glioblastoma after corticosteroid therapy.

  2009cites this paper
• Medical management of brain tumor patients.

  2007cites this paper
• Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.

  2006cites this paper
• Nanotechnology in Cancer Drug Therapy: A Biocomputational Approach

  2006cites this paper
• Pathology of primary central nervous system lymphoma.

  2006cites this paper
• Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature

  2006cites this paper
• Patients with Cerebral Gliomas Transfer Coefficient and Plasma Volume in Derived Contrast - Contrast-Enhanced MRI Preoperative Prognostic Value of Dynamic

  year unknowncites this paper